PLUR (Pluri Inc) Wutah bathi ing taun lumaku

PLUR (Pluri Inc.) - tandha merek perusahaan

Pluri Inc. develops cellular therapies to combat metabolic pathologies. The annual growth of net income per share as a percentage reflects the company's dynamics, with the latest value recorded as 0.00. The business relies on robust cold chain logistics, overcoming fierce competition from pharma behemoths. Meanwhile, the operational footprint remains minimal due to strict compliance with bio-waste disposal standards.

PLUR: Wutah bathi saben saham ing taun lumaku pluri-biotech.com 28.04.2023 - 14.11.2026

Rincian metrik keuangan lan pasar pluri-biotech.com (PLUR)

- rega saham lan prakiraan rega para ahli:
Rega Pluri|PLUR - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Kapitalisasi pasar PLUR|PLUR - Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Pluri|PLUR - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku pluri-biotech.com|PLUR - Aset Agregat Perusahaan
- indikator beban utang lan likuiditas:
Utang marang Ekuitas Pluri Inc.|PLUR - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Pluri|PLUR - Utang perusahaan|Utang-utang marang aset resik PLUR|PLUR - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Pluri|Rasio likuiditas kritis pluri-biotech.com
- informasi bathi lan kelipatan valuasi:
PLUR - Bathi resik perusahaan|Bathi sing dikarepake Pluri Inc.|PLUR - Koefisien rega marang bathi|Pangali Forward P/E Pluri|PLUR - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan PLUR|PLUR - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Pluri|PLUR - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan pluri-biotech.com|PLUR - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Pluri Inc.
- data pendapatan lan penerimaan dodolan:
PLUR - Pendapatan perusahaan|Prakiraan pendapatan perusahaan Pluri|PLUR - Multiplikator P/S|Multiplikator forward rega marang pendapatan PLUR
Analisis dhasar perusahaan:PLUR - Pluri Inc
Produk dadi Pluri Inc

Business operational efficiency is determined by the ability to generate net income per share. This metric measures the annual EPS trend, reflecting margin growth or the effect of share count reduction. For Pluri Inc. (PLUR), this trend confirms the commercialization of 3D bioreactors and the scaling of cell technologies. By analyzing the relative EPS growth over 12 months, an investor assesses the actual expansion of the business.

Pesaing utama

ASND: Wutah bathi resik saben siji saham kanggo taun lumaku|MDGL (Madrigal Pharma) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Corcept Therapeutics Corp|Wutah bathi ing taun lumaku RYTM|Wutah bathi saben saham ing taun lumaku AKRO (akerotx.com)|Wutah bathi saben saham ing taun lumaku Metsera MTSR|MoonLake Immunotherapeutics AG (MLTX) - Kacepetan wutah bathi saben saham ing taun lumaku|CRNX - Wutah bathi saben saham ing taun lumaku|NAMS: Wutah bathi saben saham ing taun lumaku|SLNO: Wutah bathi ing taun lumaku|FOLD - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku 89bio|Agios (AGIO) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Structure Pharma (GPCR)|Wutah bathi resik saben saham ing taun iki MiMedx Corp MDXG|Wutah bathi saben saham ing taun lumaku Rezolute, Inc. RZLT|LXRX (lexpharma.com) - Dinamika bathi saben saham ing taun lumaku|MBX - Wutah bathi saben saham ing taun lumaku|ALT: Wutah bathi saben saham ing taun lumaku|AARD (Aardvark Therapeutics Corp) - Wutah bathi resik saben saham ing taun iki|Sagimet Biosciences Inc (SGMT) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku BioAge Labs, Inc.|BMEA: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku QNCX|Prakiraan wutah bathi resik saben saham ing taun iki Fractyl Health Inc.|vTv Therapeutics - Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku ATPC|Synlogic Corp - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki lipocine.com LPCN|matinasbiopharma.com (MTNB) - Wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun iki SPRB|GLTO (Galecto Corp) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki Carmell Therapeutics (CTCX)|Wutah bathi resik saben saham ing taun iki LUMO (Lumos Pharma, Inc.)|Prakiraan wutah bathi resik saben saham ing taun iki organovo.com|Wutah bathi saben saham ing taun lumaku Radius Recycling RDUS